Covidien Pty Ltd

45 devices in the database

  • Model / Serial
    Solitaire Platinum Revascularisation DeviceProduct Codes: SRD3-4-20-10, SRD3-4- 40-10, SRD3-6-20-10 and SRD3-6-40-10ARTG Number: 284964
  • Model / Serial
    Covidien Curity Eye Pad, Curity Eye Pad Oval, Curity Sodium Chloride Dressing Covidien Curity Eye Pad Item Code: 03201Lot Numbers beginning with 12, 13, 14, 15 and16Covidien Curity Eye Pad OvalItem Code: 2841Lot Numbers beginning with 12, 13, 14, 15 and16Covidien Curity Sodium Chloride Dressing Item Code: 3339Lot Number beginning with 14, 15, 16 (Excluding lots: 16J098062, 16J098162, 16J098262)ARTG Numbers: 186368, 186373
  • Model / Serial
    Covidien Devon Light Glove Product Codes: 571711, 31140208, 31140216, 31140257All Lot Numbers within expiry beginning with 630XXXXXXX and lower ARTG Number: 186761
40 more

2 manufacturers with a similar name

Learn more about the data here

  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Manufacturers representative
    Allied Medical Group S.A.L - DIMA HEALTHCARE SA
  • Source
    RLMPH
  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Manufacturers representative
    DIMA HEALTHCARE SA - Allied Medical Group S.A.L
  • Source
    RLMPH